Positron emission tomography studies with the opiate antagonist [18F]cyclofoxy ([18F]CF) were per formed in baboons. Bolus injection studies demonstrated initial uptake dependent on blood flow. The late uptake showed highest binding in caudate nuclei, amygdala, thal amus, and brainstem and the least accumulation in cere bellum. By 60 min postinjection, regional brain radioac tivity cleared at the same rate as metabolite-corrected plasma, i.e., transient equilibrium was achieved. Com partmental modeling methods were applied to time activity curves from brain and metabolite-corrected plasma. Individual rate constants were estimated with poor precision. The model estimate of the total volume of distribution (VT), representing the ratio of tissue radioac tivity to metabolite-corrected plasma at equilibrium, was reliably determined. The apparent volume of distribution Va significantly overestimated V T and produced artifi cially high image contrast. These differences were pre dicted by compartment model theory and were caused by a plasma clearance rate that was close to the slowest tissue clearance rate. To develop a simple method to mea sure V T' an infusion protocol consisting of bolus plus continuous infusion (B/I) of CF was designed and applied in a separate set of studies. The Va values from the B/I studies agreed with the V T values from both B/I and bolus studies. This infusion approach can produce accurate re ceptor measurements and has the potential to shorten scan time and simplify the acquisition and processing of scan and blood data.
Summary:
Positron emission tomography studies with the opiate antagonist [18F]cyclofoxy ([18F]CF) were per formed in baboons. Bolus injection studies demonstrated initial uptake dependent on blood flow. The late uptake showed highest binding in caudate nuclei, amygdala, thal amus, and brainstem and the least accumulation in cere bellum. By 60 min postinjection, regional brain radioac tivity cleared at the same rate as metabolite-corrected plasma, i.e., transient equilibrium was achieved. Com partmental modeling methods were applied to time activity curves from brain and metabolite-corrected plasma. Individual rate constants were estimated with poor precision. The model estimate of the total volume of distribution (VT), representing the ratio of tissue radioac tivity to metabolite-corrected plasma at equilibrium, was reliably determined. The apparent volume of distribution Va significantly overestimated V T and produced artifi cially high image contrast. These differences were pre dicted by compartment model theory and were caused by a plasma clearance rate that was close to the slowest tissue clearance rate. To develop a simple method to mea sure V T' an infusion protocol consisting of bolus plus continuous infusion (B/I) of CF was designed and applied in a separate set of studies. The Va values from the B/I studies agreed with the V T values from both B/I and bolus studies. This infusion approach can produce accurate re ceptor measurements and has the potential to shorten scan time and simplify the acquisition and processing of scan and blood data. Key Words: Cyciofoxy Equilibrium-Infusion-Modeling-Opiate receptor Positron emission tomography. ment models applied to tracer doses to assess bind ing potential, and nonlinear models applied to mul tiple injection data with varying specific activities or blocking agents for quantitation of Bmax and KD (Mintun et aI. , 1984; Frey et aI. , 1985b; Farde et aI. , 1986 Farde et aI. , , 1989 Huang et aI. , 1986 Huang et aI. , , 1989 Perlmutter et aI. , 1986; Wong et aI. , 1986a,b; Logan et aI. , 1987; Frost et aI. , 1989; Salmon et aI. , 1990; Koeppe et aI. , 1991; Sadzot et aI. , 1991) . Here, we present our results with the opiate antagonist e S F]cyclofoxy (CF; 6-deoxy-6-I3-fluoronaltrexone) for receptor quantitation in baboons with PET.
CF has been extensively characterized in the rat. In vitro studies with eH]CF demonstrated binding patterns that were nearly indistinguishable from those of eH]naloxone (Ostrowski et aI. , 1987) . Rothman and McLean (1988) showed that CF binds to both f.L and K sites. In vivo studies found high extraction fraction and low plasma protein binding (Sawada et aI. , 1990) . In rat and baboon, CF plasma metabolites develop rapidly, but do not cross the blood-brain barrier (Blasberg et aI. , 1989; Sawada et aI. , 1991) . Compartmental modeling approaches have been applied to kinetic data using varying cold doses to estimate Bmax and Ko in the rat (Sawada et aI. , 1991) . The inactive enantiomer (+ )-CF has been synthesized and shown to have insignificant receptor binding (Rothman et aI. , 1988) . Studies with both enantiomers have permitted regional es timation of nonspecific binding and thereby im proved the quality of receptor measurements (Kawai et aI. , 1990a,b) . Recently, through the use of double-label infusion studies with eH]( +) -CF and t8p}( -) -C� sjmpjjiJed methodology has been developed to measure Bmax and Ko from true equilibrium studies (Kawai et aI. , 1991) .
Initial PET studies were performed using [lsF]acetylcyclofoxy in baboons (Pert et aI. , 1984; Channing et aI. , 1985) . This form of the tracer was chosen over CF to improve delivery to the brain, based on the relative delivery characteristics of her oin and morphine. However, the rapid deacetyla tion of this tracer to eSF]CF added substantially to the complexity of the required mathematical model. Once the high permeability of CF was demon strated, the acetylated form no longer provided any advantage. We now report our initial baboon PET studies with CF and our kinetic modeling ap proaches.
Ideally, PET modeling efforts lead to a complete, validated model that describes the relationship be tween PET measurements and the underlying re gional physiological parameters, including blood flow, permeability, nonspecific binding, receptor association and dissociation rates, and receptor concentration. With this knowledge, we can design a data acquisition and processing method suitable for human studies (Carson, 1991) . Initially, we aim to describe the relationship between the PET data and kinetic parameters to assess what parameter(s) can be reliably and meaningfully estimated.
We present kinetic studies with bolus CF admin istration analyzed with models using one or two tis sue compartments. We also assess whether single scan measurements provide a useful receptor mea sure. In particular, do concentration ratios of tissue to metabolite-corrected plasma (apparent volume of distribution) or tissue to nonspecific region provide receptor estimates that agree with model-based methods? Such approaches have the advantages of simplicity of analysis and shortened scan time compared with dynamic studies. Instead of measuring kinetics, scan time can be used to improve image statistical quality and anatomical sampling. In addi tion, the reduced scanning time can decrease pa tient discomfort and potentially increase scanner throughput.
We also present compartment theory of receptor binding models, which predicts that the apparent volume of distribution or tissue ratio measures may be significantly affected by the plasma clearance rate. We demonstrate this effect with CF from the analysis of the bolus injection studies. This effect can create differences in ratio measures between patient groups because of differences in plasma clearance, which could be misinterpreted as recep tor changes. To circumvent this problem, we de vised a tracer administration scheme combining bo lus injection with continuous infusion (Bll) to pro duce true equilibrium. The B/I protocol was applied in another set of studies and the results compared with the bolus data. With a simple single-scan ap proach, this infusion method can achieve the accu rate quantitation provided by bolus modeling meth ods.
THEORY Compartment models for receptor-binding radiotracers
The assumptions and definitions we applied to compartmental models follow those of many other authors (Mintun et aI. , 1984; Huang et aI. , 1986; Wong et aI. , 1986a; Frost et aI. , 1989) . Particular details of the model closely adhere to the previous CF work in rats (Blasberg et aI. , 1989; Kawai et al. , 1990a Kawai et al. , , 1991 Sawada et aI. , 1991) . Owing to the lim ited statistical quality of PET data, we propose a model that has only two tissue compartments. Com partment 1 (quantity AI) represents free (Af) plus nonspecifically bound (An) tracer. Compartment 2 (A2) represents tracer specifically bound to the re ceptor (Ar)' The definitions of the parameters are as follows (symbols are defined in Table 1 ). The deliv ery rate constant from plasma to compartment 1 is KI (mllmin/ml) and equals the product of blood flow and extraction fraction; k2 (min -I ) defines the rate constant of return from compartment 1 to plasma. We assume that, at true equilibrium, the concentra tion of free tracer in tissue water equals the concen tration in plasma water (BIas berg et aI. , 1989) . In that case, K 1 /k2, which defines the equilibrium ratio of free plus nonspecifically bound tracer to metab olite-corrected plasma CF, equals fp WT (1 + Keq) , where fp is the fraction of tracer at equilibrium not bound to plasma protein and is measured via ul- (receptor bound) (min -I) Rate constant from tissue compartment 2 to 1 (min -I) Magnitude of bolus in bolus plus continuous infusion protocol (min) Equilibrium dissociation constant (nM) Equilibrium association constant of nonspecific binding (dimensionless) Dissociation rate constant (min -I) Bimolecular association rate constant (nM-I min -I) Apparent ratio of region of interest to reference region Equilibrium ratio of region of interest to reference region Apparent total volume of distribution (mIlml) Equilibrium total volume of distribution (ml/ml) Equilibrium total volume of distribution of reference region (ml/ml) Effective vascular volume (ml/ml) Water content of tissue (ml water/ml brain) trafiltration (ml plasma/ml water); WT is the water content of tissue (ml water/ml brain), which is as sumed to be the distribution space for the receptors; and Keq is the equilibrium association constant for nonspecific binding (An/Af) ' Although we assume that K1/k2 is linearly proportional to fp , we do not assume that the same is true for the influx rate con stant K1• In other words, the equilibrium between free tracer in plasma and protein-bound tracer may be maintained on a time scale faster than a single capillary transit time. The parameter k3 is the rate constant of transfer from compartment 1 to 2. As- (Rothman and McLean, 1988) . These binding sites may be kinetically indistinguishable, however, at least in rats (Kawai et aI. , 1991) . For regions with no specific binding or where the parameters of the two tissue compartments cannot be identified, a model with one tissue compartment is used. We emphasize that, at this point, we use these models to characterize the kinetic curve. Any physiological meaning ascribed to the parameter estimates of the models must be validated.
AT

Total volume of distribution (V T)
The concentration ratio between tissue and free tracer in plasma at equilibrium is defined as the total volume of distribution. We chose the free tracer concentration as the reference because it provides a more natural mathematical relationship between V T and Bmax ' Although true equilibrium is never achieved after a bolus injection, V T can be esti mated from the fitted model parameters by setting all derivatives equal to zero. For the model with two tissue compartments,
For the one-compartment model,
The physiological interpretation of V T can be de rived from equilibrium considerations:
where Ay is the radioactivity concentration in the vascular space and Vy is an effective vascular vol ume (the ratio of the concentration of vascular ra dioactivity to the concentration of tracer in plasma water). Again assuming that the tracer concentra tion in tissue water equals that in plasma water at equilibrium, i. e. , Af/wT = fp Cp ' then where AjAf' the bound-to-free ratio, is equal to the ratio of free receptor concentration (B:naxiwT) to KD, assuming tracer conditions. In regions with no specific binding, the equilibrium volume of distribu
An alternative measure to V T that is useful when metabolite-corrected plasma is not available is RT, the concentration ratio between receptor-rich (AT) and receptor-poor (AT) regions:
This assumes that the level of nonspecific binding is equal in the two regions.
Transient equilibrium
For reversible ligands, apparent equilibrium can be reached after a bolus injection. This condition occurs when a constant ratio of tissue to blood ra dioactivity is maintained over time (or a constant ratio between tissue regions). Although radioactiv ity is clearing from plasma and tissue, the clearance is at the same fractional rate, so a constant ratio is obtained. Following the terminology of parent daughter decay of radiation physics (Evans, 1955) , this condition is defined as "transient equilibrium. "
Va' the apparent volume of distribution [AT(t)/ fpCp(t)], reaches a constant value during transient equilibrium. Ideally, for bolus studies, Va would equal the ratio at true equilibrium (VT), and a single scan and a single blood sample could provide recep tor information using Eq. 3. However, we demon strate in Appendix A that during transient equilib rium, Va > VT . The magnitUde of this overestima tion depends on the rate of plasma clearance and the local tissue kinetics. A similar error occurs when using the ratio between tissue regions. If Ra is the apparent ratio between a region of interest (ROI) and a reference region with no receptors, i. e. , Ra = AT(t)/A'T(t), Ra > RT as well (Appendix A).
Programmed infusion
One approach to measure V T is to maintain con stant blood and tissue concentrations by adminis tering radioactivity as a programmed infusion in stead of a bolus. Patlak and Pettigrew (1976) de vised a method to generate infusion schedules that can produce various input function forms. Their method has been employed particularly to produce a constant input function. This method has been extended to produce an infusion schedule that rap idly generates constant radioactivity levels in blood and all brain regions to measure the volume of dis tribution of eSO]water (Carson et al. , 1988a; Hers covitch et al. , 1989) . This same approach can be used to produce true equilibrium for receptor stud ies so that V T can be measured directly. In this study, we have defined the infusion schedule to consist of a combination of bolus and continuous infusion. The single parameter to be specified in this administration scheme is the magnitude of the bolus 
METHODS
Radiosynthesis of [18F]CF
Aqueous [18F]fluoride (100-150 11-1, -100 mCi) was added to a clean 5-ml V -vial already containing tetra methylammonium hydroxide (30 11-1, 30 mM). The con tents were dried with a stream of argon (block tempera ture at 100°C), and any residual water was removed by evaporation with anhydrous CH3CN (3 x 300 11-1). To the residue was added the (-)-3-acetyl-6a-naltrexol trifluo romethanesulfonate (2.0 mg, 4 I1-mol) in 400 11-1 CH3CN; the vial was capped and the contents were allowed to react at 100°C for 15 min. The vial was cooled, and then with only slight warming, the CH3CN was concentrated with a stream of argon to -50-100 11-l. The reaction mixture was transferred to a Bond Elut Si Silica cartridge (500 mg; Varian) with 2 x 1 ml CHC13 and eluted with CHC13/CH30H/NH40H (99: 1 :0.1). The first 4 ml of eluate was discarded and the next 6 ml, which con tained the crude product, collected. The solvent was evaporated with argon at 60°C and the residue dissolved in 125 11-1 CH3CN plus 125 I.Ll HPLC eluant (28% CH3CNI 72% 5 mM triethylamine/5 mM sodium dihydrogen phos phate, pH 3.0, buffer). The crude sample of ( -)-3-acetyl6a-[18F]CF (Channing et aI., 1985) was further purified by semipreparative HPLC (Beckman Ultrasphere-ODS, 5 11-, 10.0 x 250 mm). The acetylated 6-P8F]CF was collected (k' = 9.3), and a major portion of the CH3CN was evap orated with a stream of argon (5 min at 55°C). To this was added 28% NH40H (0.5 ml); the mixture was vortexed and heated at 55°C for 3 min. The mixture was applied to a CI S octadecyl Bond Elut cartridge (500 mg; Varian), which had previously been rinsed with 10 ml each of eth anol and water. The cartridge was rinsed with 10 ml wa ter. The 6u-e S F]CF was eluted with 2 ml absolute etha nol, and the ethanol was evaporated. The product was formulated by sequential addition and thorough mixing of 100 ILl ethanol, 100 ILl 2 N acetic acid, and 10 ml 3.8% (wt/vol) sodium citrate for injection (NIH Pharmaceutical Development Service) and sterilized by filtration through a 25-mm, 0.22-lLm filter (Millex-GV; Millipore). The yield of final product was 38.5 ± 5.9% and the measured ra dioactivity averaged 17.6 :t: 8.8 mCi (n = 8, decay cor rected to end of bombardment). The total synthesis time was 100 min. The specific activity (at end of bombard ment) averaged 10.7 ± 8.8 Ci/lLmol (n = 8), and both chemical and radiochemical purity were >98% as deter mined by HPLC (Beckman Ultrasphere-ODS, 5 IL, 4.6 x 250 mm, 30% CH3CN170% 5 mM triethylamine/5 mM so dium dihydrogen phosphate, pH 3.0, buffer).
Animal studies
Eight PET studies were performed in laboratory-bred male baboons (Papio sp.) ranging in weight from 15 to 25 kg. Animals were anesthetized intramuscularly with ke tamine, typically 10 mg/kg every 30 min. Endotracheal �ntubation was performed for control of respiration, an mtravenous line was inserted in a distal lower extremity, and a femoral artery catheter was inserted on the contra lateral side by either percutaneous puncture or cut-down and sutured in place. The animals were transported to the PET suite and were positioned on the scanning table. Prior to and during scanning, Pavulon (0.03 mg/kg i. v. every 90 min) was administered to paralyze the animals. Blood pressure, temperature, and ECG were continu ously monitored. Ventilation was controlled with a Ben nett ventilator, end-tidal Peo2 was continuously moni tored, and arterial blood gases were serially sampled. A thermoplastic mask was fitted to the animal's head to maintain its position in the scanner. All studies were per formed under a protocol approved by the NIH Clinical Center Animal Care and Use Committee.
Administration of CF
Four studies were performed with bolus administra tion, and four studies used a combination of bolus plus continuous infusion (BII). For bolus studies, 4-7 mCi of CF was administered intravenously over a I-min period. This period was chosen to reduce sensitivity to errors in blood sampling. In the B/I studies, a computer-controlled pump (Harvard model 22, South Natick, MA, U.S.A.) was used to ensure accurate and reproducible adminis tration of radioactivity. The dose was diluted with saline to a total volume of 50 ml. The bolus fraction of the dose (plus sufficient volume to fill the catheter dead space) was administered at the pump's highest speed (26 ml/min).
�ump speed was changed by computer at the appropriate time to administer the remaining dose uniformly. In one B/I study, the infusion was purposely interrupted after 70 min to alter plasma clearance, and scanning was contin ued until 120 min. In two studies, the infusion continued until 120 min. One study was terminated at 60 min. 2:30,3,4,5,7, 10, 15,20, 30, 40, 50, 60, 75,90 , and 120 tDin. Samples were centrifuged, and 0.3 ml of plasma was counted in a calibrated gamma counter. At least 12 samples were analyzed by an ethyl acetate extraction procedure to determine the fraction of radioactivity representing unmetabolized CF (Kawai et al., 1 990b). This procedure has been validated against HPLC measurements in rat and baboon plasma Sawada et al., 1991) . A 100-1L1 aliquot of plasma was added to 300 ILl of borate buffer (pH 9.0; 0.2 mM) followed by 400 ILl of ethyl acetate. The sample was vortexed (> 10 s) and centrifuged at 13,000 g for 1 min. Samples of the organic and aqueous phases were pipetted (200 ILl) and counted in a gamma counter. The fraction of un metabolized CF (F cp) was determined from the ratio Cj(Co + Ca), where Co and Ca are the concentrations in the organic and aqueous phases, respectively. The frac tions were normalized to the extraction efficiency of this procedure, which was determined by a sample consisting of -5 ILCi of CF added to 5 ml of nonradioactive blood. The efficiency was 96.2 ± 0.8% (SD). After deletion oj outliers, data were smoothed by fitting overlapping five· point segments to quadratic polynomials. A continuom curve was passed through these points using cubic spline� (Carson et al., 1981) . The metabolite-corrected CF inpU' function (C p) was calculated from the product of the F CI curve and the total plasma radioactivity (C tot ) .
Blood sampling and metabolite determination
The fraction of CF in plasma bound to pl�sma protein: was determined by ultrafiltration (Sawada et aI., 1990) 300 ILl of plasma from the sample used to measure ethy acetate efficiency was applied to a Centrifree microparti tion membrane (Amicon, Danvers, MA, U.S.A.) and cen trifuged for 15 min at 2,000 g. The free fraction in plasm (fp) .
wa � calculated from CjCp, where Cu is the concer tratlon m the ultrafiltrate (nCilml plasma water). This pre cedure was not performed in the initial studies describe here. Therefore, a mean!, value calculated from the n maining studies and from P another series of CF studit was applied in the calculations. Me.
sured fp values were 0.7456 ± 0.0264 ml plasma/n plasma water (n = 11).
PET scanning procedure
Scans were performed with the Scanditronix PC 102· 7B brain tomograph (Daube-Witherspoon et al., 1987 which acquires seven simultaneous slices, 13.75 m apart. Reconstructed in-plane resolution is 6.5 mm ar axial resolution is 1�12 mm. The baboons were �o� tioned so that slices were parallel to the orbitomeatal lin Transmission scans were acquired with either a ril source or a rotating rod source. Dynamic scans were a quired beginning with tracer arrival in the brain. Ima reconstruction included corrections for attenuation, sc. ter, randoms, and deadtime. Pixel values were calibrat in nanocuries per cubic centimeter with a uniform pha tom filled with ISF. The baboon brain was visible in thr to four adjacent slices. Images were summed from 0 to min post injection and 60 to 120 min to improve statist for the purpose of identifying ROIs. Slices were matcb to a baboon brain atlas (Riche et al., 1988) and RC (circular and irregular) of size 1-4 cm2 (4 mm2/pixel) WI placed on the images. Regions were drawn on both hel spheres on the cerebellum, frontal, temporal, and parit cortex (two levels), caudate nuclei, amygdala, and wt matter (centrum semiovale). Single midline regions w drawn for occipital cortex and thalamus.
Data analysis
Decay-corrected time-activity curves were fit to three different models. Model 1 included two serial tissu'! com partments and four parameters and is described mathe matically by Eqs. AI, AlD, and All of Appendix A. To minimize errors due to vascular radioactivity and time shifts between brain and blood measurements, data col lected before 3 min post injection were not used with model 1. Model 2 is a five-parameter model, which in cludes a term for vascular radioactivity of the form V pc� ot and was applied to scan data beginning at injection time. Model 3 is a reduced model consisting of one tissue com partment plus vascular radioactivity and has three param eters (Kj, kz, Vp). In the implementation of all models, the input function is considered to be piecewise linear be tween sample points, and the tissue model includes inte gration over each scan interval. Parameter estimates are derived by weighted nonlinear regression, where weights are chosen as the inverse of the variance of the ROI value determined by Budinger's formula (Budinger et aI., 1978) modified to account for region size and random counts. The covariance matrix of the parameter estimates, pro duced by the fitting procedure, is used to calculate stan dard errors of functions of the rate constants including VT• The quality of the fits to models 1-3 was compared using the Akaike information criterion (AIC; Akaike, 1976) :
where n is the number of data points, WSS is the weighted sum of squares, and p is the number of parameters. Pa rameter estimates for bilateral ROIs were averaged.
RESULTS
Bolus studies
Typical plasma time-activity data after a bolus CF injection are shown in Fig. 1 . Figure lA depicts total radioactivity, which dropped rapidly, with a clearance rate of 1.4 ± O.4%/min (n = 4) from 20 to 120 min post injection. Figure IB shows the per centage of that radioactivity that was extracted in ethyl acetate: 40.8 ± 5.7% at 5 min, 25.8 ± 2.8% at 10 min, 21.1 ± 1.7% at 20 min, 13.7 ± 1.3% at 60 min, and 11.9 ± 2.2% at 120 min (n = 4).
These studies used high specific activity CF (> 1 Ci/fLmol). By 20 min post injection, the plasma con centration of free CF was below 10 nCi/cc, resulting in a cold concentration of <0.01 nM. With mea sured Kn values of 0.34-1.5 nM in vitro (Rothman and McLean, 1988 ) and 1-2 nM in vivo (Kawai et aI., 1991) , and assuming that the free tissue CF con centration is comparable with that in plasma, there was essentially no change in receptor occupancy caused by the injected CF. The peak tissue concen tration was 1,000 nCi/cc or <1 nM. Even assuming that 100% of the radioactivity was receptor bound, < 10% of the receptors would be occupied based on in vitro and in vivo Bmax values (Rothman and McLean, 1988; Kawai et aI., 1991) . Images from a bolus injection study are shown in Fig. 2 . The top row of images are averages of scans collected 0-10 min post injection. They portray a radioactivity distribution very similar to that seen in cerebral blood flow studies with [ 1 50]water (data not shown). The late images, which are produced by averaging scans from 60 to 120 min post injec tion, show a markedly different radioactivity pat tern. The highest accumulation of tracer occurred in caudate nuclei, amygdala, thalamus, and brains tern , while the least accumulation occurred in cerebel lum. High uptake can also be seen in the pituitary.
Sample tissue time-activity curves for the study depicted in Figs. 1 and 2 are shown in Fig. 3A . The data peak -5 min post injection and then decline rapidly. Transient equilibrium between tissue re gions and plasma is assessed by plotting the appar ent volume of distribution (Va) versus time (Fig.   3B) . A constant ratio of tissue to metabolite corrected plasma is reached by 10 min in cerebel lum, the region with lowest binding. Constant Va is reached at later times for regions with higher bind ing.
Models 1, 2, and 3 were applied to all ROIs. The means and standard deviations of rate constants de-rived from model 1 (four-parameter model) are pre sented in Table 2 . Figure 3A shows examples of the quality of fits obtained using model 1. The KJ values are quite high, consistent with a lipophilic tracer with low protein binding (Fenstermacher et aI., 1981) . The k4 values, presumably k O ff' were reason ably uniform across brain regions and had lower variability among animals in regions with high bind ing. The estimates for k2 and k3' however, are highly variable. Ideally, k3 values would reflect free recep tor concentration; i.e., the highest values would be in regions with highest binding. This was not the case. Instead, this model tended to produce esti mates of k2 that were lower in the regions with higher total binding. The volume of distribution for free plus nonspecifically bound tracer (K J /kJp) ranges from 4 to 9 mllml in cerebellum and cortical regions and from 11 to 16 ml/ml in thalamus, amygdala, and caudate. This model-based estimate of free plus nonspecific binding disagrees with mea sured values using the inactive enantiomer ( + )-CF in both rats and baboons (Carson et aI., 1989; Kawai et aI., 1990a) . In baboons, the ( + )-CF vol ume of distribution was 6-8 mllml for all brain re gions (after correction for fp), and regions with higher specific binding did not have higher nonspe cific binding. Although the quality of the fits is quite good, the estimated parameter values are not con sistent with their conventional physiological inter pretation.
Even though individual parameter values were highly variable, the total volume of distribution (Eq. 1), a parameter sensitive to receptor concentration Values are means (SD) of rate constants derived from fit of data between 3 and 120 min post irljection in four bolus injection studies using model I (four parameters , two tissue compartments).
(Eq. 3), was estimated with much higher accuracy. For example, the mean coefficients of variation (ra tio of the parameter's standard error to its value) for model 1 were as follows: K!, 6. 6%; k2, 21. 4%; k3' 58.2%; k4' 26. 0%. For VT, the coefficient of varia tion was typically 1-2%. Since VT can be estimated by all three models, values were chosen from the model that provided the best fit, as determined by the lowest AIC. Occasionally, however, the AIC chose a fit that estimated VT with a substantially larger standard error. Therefore, to ensure that VT was estimated reliably, a model with a lower AIC was not selected as the best fit if its predicted stan dard error of V T exceeded that of model 3 by > 10%. The coefficient of variation across animals ranged from 8 to 23%. If nonspecific binding is assumed to be uniform and cerebellar binding is considered to be predominately nonspecific, then specific binding accounts for 75-80% of VT in receptor-rich regions and 50-60% of VT in cortical regions. Resolution limitations certainly affect these values, both in the small receptor-rich regions (caudate, amygdala) and in regions such as cerebellum, owing to transverse and axial partial volume effects (Hoffman et al. , 1979; Kessler et aI. , 1984) .
To assess the stability of the V T estimates, fits to just the first 60 min of each data set were per formed. In this case, convergence did not occur for 24 ROIs for model 1 and 13 ROIs for model 2. The The errors are smaller than those with Va because there is some cancellation of errors due to overes timation in the reference region (Eq. AI6).
B/I studies
With use of the bolus study results, a B/I admin istration scheme was determined (Appendix B). For each animal, the time-activity curves in plasma, cerebellum, and thalamus were used to determine the bolus portion of the dose (Kbo1)' The mean value was 75. 1 ± 9. 0 min (n = 4). An example of the predictions of the optimization is shown in Fig. 5 for the baboon whose data were shown in Figs. 1-3. The predicted curves for plasma (Fig. 5A ), thala mus (Fig. 5B) , and cerebellum ( Fig. 5C ) are shown
for Kbo1 values of 50, 75, and 100 min. The optimi zation chose a Kbo1 value that produced a constant level for all curves at similar times. For example, a lower Kbo1 value of 50 produced more rapid plasma equilibrium but slower equilibrium in the thalamus. Four B/I studies were performed. In one study, in the same animal whose data are shown in Figs. 1-3 , the infusion was interrupted at 70 min post injec tion. The purpose of this interruption was to dem onstrate with measured data the sensitivity of Va to the plasma clearance rate. Figure 6 shows the re sults of this study. Radioactivity in the plasma (Fig.  6A and B) and tissue regions (Fig. 6C) reached steady levels by 20 and 30 min, respectively. At 70 min post injection, the infusion was discontinued, and plasma and tissue concentrations dropped. The unmetabolized fraction of CF in plasma also dropped to levels similar to that in the bolus studies. Figure 6D shows the apparent volume of distribu tion (V J plotted against time. Discontinuing the in fusion caused a dramatic increase in Va in thalamus and smaller increases in frontal cortex and cerebel lum. This change is due solely to the change in clearance from plasma and demonstrates that Va can be significantly affected by plasma clearance. It is interesting to note that the entire 120 min of data of this study can be fitted well with model 1 (Fig.  6C) .
The B/I infusion protocol was applied in three additional studies. Sample results are shown in Fig.  7 . The average plasma clearance rate was +0.06 ± 0. 12%/min from 20 to 60 min. The unmetabolized fraction in plasma was 25. 9 ± 11. 9% at 20 min and 26. 0 ± 10. 5% at 60 min, substantially higher than the comparable values from the bolus studies. The mean tissue clearance rates from 20 to 60 min were -0. 27 ± 0. 38%/min in thalamus, + 0.21 ± 0. 29%/ min in frontal cortex, and + 0. 38 ± 0. 35%/min in cerebellum. This pattern is similar to the predicted curves of Fig. 5 , which show a small rise in thala mus (negative clearance rate) and a small down ward trend in frontal cortex and cerebellum. The time-activity data were fit to the three models, the best fits were determined, and the resulting VT val ues are tabulated in Table 4 for fits of 0-120 min (n = 2) and for 0-60 min (n = 4). The mean percent age differences (across ROIs) between VT values from the infusion studies and the bolus studies (0-120 min) were 3. 8 ± 15. 4% 020-min fits) and 4. 1 ± 12. 5% (60-min fits). There is much better agreement between Va and VT for the B/I studies than for the bolus studies (Fig.  4A) . The mean percentage difference (across re gions) between Va values from infusion studies (40-60 min) and VT values from bolus studies (120-min fits) was 5. 8 ± 14. 7%. Figure 8B shows the rela tionship between the apparent tissue ratios (RJ and the fitted values (RT). Agreement is similarly much better than the bolus study results (Fig. 4B) .
DISCUSSION
The primary goal of this study is to evaluate methods to obtain reliable and physiologically meaningful receptor measurements with e S F]CF and PET and to specify a suitable protocol for hu- Time (min) man studies. The extensive evaluation of CF in the rat provided an excellent basis for the development of modeling methodology. However, the consider able differences between PET data and autoradio graphic or tissue-sampling measurements, as well as the species differences between rodents and pri mates, may limit the applicability of the information obtained in the rat experiments. For example, PET studies allow acquisition of mUltiple time points in a single study, avoiding interindividual variability. However, the spatial resolution and statistical reli ability of PET data are substantially worse than in rat measurements. Therefore, kinetic parameters that can be reliably measured in rat studies may not be numerically identifiable from PET data.
Conventional compartment modeling and parameter estimation
The time-activity data after bolus injections were analyzed using compartmental modeling tech niques. Model l included two tissue compartments and was applied to data acquired after 3 min post injection to avoid the effects of vascular radioactiv ity. Model 2 added vascular radioactivity and was applied to the full data set. Note that because of the high permeability of CF, vascular radioactivity should not introduce significant errors, since the venous drainage rapidly equilibrates with the free pool in tissue. However, the presence of radioac tive metabolites at later times will slightly bias the results from model 1. Model 3 (one tissue compart ment plus vascular radioactivity) was originally in cluded for fits to regions with little or no specific binding. Ideally, reliable parameter estimates could be obtained in receptor-rich regions using models 1 or 2. These parameter estimates would in theory allow direct measurement of delivery, nonspecific binding, the binding potential, and receptor disso ciation rate. Although convergence could be achieved for most ROIs, and model 1 was found to be most suitable according to the Akaike informa tion criterion, the model 1 parameter estimates were variable across animals and the values were not consistent with their expected physiological in terpretation. The ratio K/kJp' the equilibrium dis tribution volume for free plus nonspecifically bound tracer, showed a wide variation across regions, with higher values in receptor-rich areas. This result conflicts with studies of the inactive enantiomer ( + )-CF in rats and baboons (Carson et aI. , 1989 ; Kawai et aI. , 1990a), which showed lower nonspe cific binding levels and smaller nonuniformities. There are many possible reasons why the model 1 estimates are not consistent with physiological ex pectations. The presence of binding to two receptor sites poses a problem, but this did not limit the use of even more complex kinetic models with rat data (Sawada et aI. , 1991) . Primarily, there is low sensi tivity to the parameters k2 and k3 in the measured data, as seen by their large standard errors. Usu ally, standard errors are a lower bound on the true variability of the results, because of error sources that are not included in the model (Carson, 1991) . In addition, there are biases introduced in the fits ow ing to effects such as uncorrected scatter in the tis sue data, errors in metabolite corrections, and time shifts between brain and plasma data. These effects can significantly alter parameter values, particu larly when sensitivity to the parameters is low. When only 60 min of data was used, best fits to models 1 or 2 could be achieved for only 60% of the regions. These results suggest that, without addi tional constraints, it is highly unlikely that individ ual parameters can be reliably estimated in human studies, particularly considering the reduced statis tical image quality (due to dosimetry consider ations) and additional variability introduced by pa tient motion.
One approach to improve precision is to limit the number of floating variables. For example, because of the high extraction of CF, K 1 could be estimated (rom measured blood flow values and an assumed value for P S. Alternatively, the nonspecific binding level could be estimated from a region with little or no binding. For example, Frost et ai. (1989) used parameters from occipital cortex fits to limit the number of floating parameters in fits of high binding regions. Another method is to use an inactive en antiomer that can properly account for regional variations in nonspecific binding, but requires an additional study. These techniques are useful to ex tract the most information possible from PET ki netic data. Validation studies, however, are neces sary to verify the accuracy of the assumptions and assess the magnitude of propagation of errors Carson, 1991) .
The parameter that is most reliably estimated from kinetic data is VT, the total volume of distri bution. VT should equal the concentration ratio of tissue to free, metabolite-corrected plasma at true equilibrium. V T is a measure of receptor concentra tion (Eq. 3), has small variability, and is, to a great extent, model independent. V T can be estimated by models 1, 2, or 3. The robustness of this measure is shown, to some extent, by the good agreement be tween 60-and 120-min fits and between the different model fits. There is a small bias in the model 3 values compared with model 1. Part of this differ ence is due to vascular metabolites, which are not included in model 1 and will cause a slight overes timation of VT . The difference, Vy (Eq. 3), is the ratio of vascular radioactivity (nCi/ml brain) to the CF concentration in plasma water and can be ap proximated as Mean (SD) total distribution volume values for infusion studies. V T values determined from best fit of data from 0 to 120 (n = 2) and o to 60 (n = 4) min. See text for details of models and choice of best fit. V a ' the apparent volume of distribution, is determined from 60 to 120 (n = 2) and 40 to 60 (n = 4) min . All values ha 'V e been adjusted for plasma free fraction.
where Vb is the blood volume (mllml). For FCF == 0.13 (60-120 min) and Vb = 0.05, the VT error for model 1 is 0.52 mllml, half of the difference between models 1 and 3.
V T was estimated from the model that provided the best fit according to the Akaike information cri terion (Akaike , 1976) . In some cases, this produced an estimate of V T with a large standard error. This was more often the case when only 60 min of bolus data was used or when the B/I studies were ana lyzed. Therefore , since VT is the primary parameter of intere st, the fit with the lowest AIC was not cho sen if the standard error of V T increased by > 10%
over the estimate from model 3. The model 3 esti mate was used as a baseline because it had the few est parameters and always converged. Model 3 can easily be implemented on a pixel-by-pixel basis in a similar manner to blood flow measurements (Holden et al . , 1981) . The same approach has been used by Koeppe et al. (1991) for pixel-by-pixel quantitation of the benzodiazepine receptor.
Alternatives to conventional compartment modeling If V T is the only parameter that is reliably esti mated, it is worth considering if there are simpler data acquisition protocols or analysis schemes to measure it. With use of bolus injection data, V T can be estimated by the ratio of the integrals to infinity of the tissue radioactivity to metabolite-corrected plasma radioactivity (Lassen and Perl, 1979) . This requires extrapolation of the measured data to in finity. An interesting alternative approach is that proposed by Logan et al. (1990) whereby a data transformation produces a linear plot whose slope equals V T' When applied to CF data, this plot reaches linearity by 10 min post injection, and esti mates of the slope are in good agreement with VT values determined from the compartmental models (data not shown). One technical issue in this method is the estimation of a slope from data when both dependent and independent variables are noisy and correlated (Beck and Arnold, 1977) . This may produce small biases in the results.
Tissue ratios and transient equilibrium
The previous methods require full time-activity curves in both plasma and brain regions. As shown in Fig. 3B , a constant ratio of tissue to plasma is achieved by 60 min post injection. The time to reach equilibrium is determined by the eigenvalues of the tissue response fu nction (cxi; Eq. A2). Regions with high binding levels have smaller eigenvalues and require longer periods to achieve transient equilib rium, which occurs when those exponential terms have become negligible (Eq. A5). Ideally, at tran sient equilibrium the apparent volume of distribu tion (V J could be used as an index of receptor con eentratjon. Th e derjvatjons presented in Appendix A, to e aifkren ces between P; ana' FT sho wn In Hg.
4A, and the dramatic change in Va seen in the dis continued infusion study (Fig. 6D) Fig. 4) , the slopes could vary across patient groups if plasma clearance rates differ.
True equilibrium by tracer infusion
A straightforward approach to eliminate the bi ases of transient equilibrium measure s is to admin ister the tracer in a manner that produces true equi librium, i.e., constant radioactivity levels in plasma and all brain compartments. Patlak and Pettigrew (1976) devised a technique for determination of an optimal infusion scheme to rapidly produce con stant blood levels. This approach has been used for the measuremen t of the lumped constant of deoxy glucose (Sokoloff et aI ., 1977) and for receptor mea surements (Frey et aI ., 1985a) . In this study and our previous rat equilibrium study (Kawai et aI ., 1991) , the determinatio n of infusion schedule (Appendix B) was modified in two ways. First, the schedule wa s deli ned to bring both blood and all brain regI ons /0/0 equ/uonUD7 as qUIckif as poss/b/e , an ap proach previously applied to measure the distribu tion volume of [150] water (Carson et aI ., 1988a; Herscovitch et aI ., 1989) . Second, since it is imprac tical to obtain a preliminary bolus measurement (particularly in patient studies), an infusion tailored to each individual cannot be determined. Therefore , a single infusion schedule, consisting of a B/I ad ministration, was applied to all animals.
The results fr om our B/I studies are consistent with the theoretical predictions . The infusion scheme designed from the bolus data produced con stant radioactivity levels in plasma and brain re gions. There was good agreement between the fitted V T values in bolus and infusion studies and also with the tissue-to-blood ratio (Va) measured during the equilibrium period of the B/I studies. This con gruence between theory and observation is in itself a validation that model-based measurements are re liable. Further studies are required to validate the physiological accuracy of the results .
The B/I administration protocol provides many advantages over bolus studies. By achieving equi librium, VT measurements can be peIformed with a single scan and a single blood sample and metabo lite measurement. For more reliability , a few short scans can be acquired to verify equilibrium and a few blood samples can be analyzed. Data process ing is simple and pixel-by-pixel computations are straightforward , although this can also be achieved with model 3. In human studies, the subjects need not be in the scanner during the initial phase of the study . Scanning and blood sampling are required only during the equilibrium phase and attenuation corrections can be peIformed using postinjection transmission scans (Carson et aI ., 1988b) . The need for fewer metabolite measurements would be a sig nificant improvement for tracers requiring HPLC determinations. For CF studies using ethyl acetate extraction, the reliability of these measurements is improved with the B/I protocol because the fr action of un metabolized CF is higher (Fig. 6B) . Also, since kinetic data are not required, scans can be acquired at interleaved axial levels to improve the spatial sampling, which is important for small receptor-rich structures. Finally, for tracers like CF that bind to multiple receptor sites, the equilibrium approach provides an accurate measure of total binding, i.e., where the superscripts refer to fL-and K-receptor subtypes.
Infusion studies also have limitations. The B/I protocol will not produce equilibrium for subjects with significantly different blood kinetics or for re gions with receptor concentrations or affinities out side the range used by the optimization procedure . As suggested above, instead of a single scan during the equilibrium period, multiple short scans (at the same or alternating anatomical levels) could be ac quired to verify equilibrium. If equilibrium is satis factory, the individual images could be averaged to improve statistical quality. In addition, if multiple blood points and metabolite measurements are taken, small residual deviations fr om equilibrium could be corrected. For example, with population average values for rate constants as in the tluoro deoxyglucose operational equation (Huang et aI ., 1980) , equations such as A14 could be used to de termine V T' Such a correction would require an ac curate measurement of the residual plasma clear ance 13. Without correction, small residual plasma clearance, randomly distributed about zero, will add to population variability . A practical disadvan tage of infusions is that if there is some technical difficulty with the infusion (e.g., pump failure), the study may be lost.
Quantitation of receptors from the total volume of distribution
To (Carson et aI ., 1991) .
SUMMARY
Bolus injections of the opiate antagonist e8F]CF produce PET data that allow reliable measurement of the total volume of distribution by conventional compartmental analysis with different models. However, individual kinetic parameters of models with two tissue compartments cannot be estimated reliably. Transient equilibrium between brain re gions and plasma occurs within 60 min. The con centration ratio of tissue regions to plasma or to nonspecific tissue regions during transient equilib rium overestimates values at true equilibrium owing to plasma clearance. This effe ct is present to some degree for all reversible receptor binding radiophar maceuticals and produces large errors for CF. The combination of bolus plus continuous infusion can produce true equilibrium and permits a direct mea surement of the total volume of distribution. This approach may prove useful in human studies by al lowing simpler protocols for scanning and blood measurements with the potential for more reliable re sults.
APPENDIX A APPARENT VOLUME OF DISTRIBUTION Va
This appendix presents the theory relating the ap parent volume of distribution (Va) that is achieved during transient equilibrium to the equilibrium vol ume of distribution (VT).
General model
Consider an arbitrary linear compartment model with metabolite-corrected input function Cp(t), im pulse re sponse fu nction h(t) , and tissue concentra 
If 13 is much smaller than k2 ' then Va will only slightly overestimate V T' However, if 13 is compa rable to k2' the overestimation will be large. Note that Eq. A9 is the basis of the continuous inhalation method for cerebral blood flow (Frackowiak et aI ., 1980) . For blood flow, instead of clearance (13 > 0) , the decay-corrected input fu nction is exponentially increasing (Selikson and Eichling, 1982) with the half-life of 150 (13 = -In 2It1/) . Therefore , Va dif fers from VT and depends on flow (KI). For receptor applications, tissue and blood data are decay cor rected , and decay plays no role in transient equilib rium.
Two tissue compartments
For a model with two tissue compartments in se ries, the impulse response fu nction is where the eigenvalues are (All)
The equilibrium volume of distribution (Eq. A3) be comes If 13 is one-half of ai' then the apparent volume of distribution at transient equilibrium will be approx imately twice the distribution volume at true equi librium.
Tissue ratios
Suppose the ratio between a region with specific binding and a region without specific binding is of interest. If the background region can be described by a one tissue compartment model and the specific region requires a model with two tissue compart ments, then the ratio at true equilibrium between these regions will be (A1S) where V� represents the distribution volume of the reference region and K,/k2 is assumed to be identi cal for the two regions. At transient equilibrium, the ratio will be where K; and k; are the corresponding rate con stants for the background region . The relative error in Ra (compared with RT) will be smaller than Va (compared with V T) because of cancellation of some of the errors in the denominator V�. where gi(t) is the predicted B/I curve for region i from Eq. B2, and Wj is a weight that can be used to increase the importance of the later time points. This approach minimizes the percentage difference between all curves and their final value.
